| |
| |
|
| Insider
Information: |
Olson Laurie J |
| Relationship: |
|
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
87,910 |
|
|
Indirect Shares
|
5,529 |
|
|
| Direct
Value |
$2,289,713 |
|
|
|
Indirect Value
|
$154,867 |
|
|
| Total
Shares |
93,439 |
|
|
| Total
Value |
$2,444,580 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Pfizer Inc |
PFE |
Executive Vice President |
2018-08-13 |
72,672 |
2018-08-13 |
5,529 |
Premium* |
|
|
Quanterix Corp |
QTRX |
|
2024-04-01 |
15,238 |
2021-04-27 |
0 |
Premium* |
|
|
Karuna Therapeutics, Inc. |
KRTX |
|
2024-03-18 |
0 |
2021-06-07 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
70 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PFE |
Pfizer Inc |
Executive Vice PresidentOffice |
• – – |
2012-07-17 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
45,927 |
|
- |
|
| PFE |
Pfizer Inc |
Executive Vice PresidentOffice |
• – – |
2012-07-17 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,698 |
|
- |
|
| PFE |
Pfizer Inc |
Executive Vice PresidentOffice |
• – – |
2012-07-17 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
45,297 |
|
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2013-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
15,627 |
55,660 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2014-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
5,830 |
73,997 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2014-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
6,486 |
56,567 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2015-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
2,876 |
84,116 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2016-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
3,603 |
80,362 |
0 |
- |
|
| QTRX |
Quanterix Corp |
|
– • – |
2021-04-27 |
4 |
A |
$0.00 |
$0 |
D/D |
4,540 |
4,540 |
0 |
- |
|
| QTRX |
Quanterix Corp |
|
– • – |
2022-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
2,668 |
7,208 |
0 |
- |
|
| QTRX |
Quanterix Corp |
|
– • – |
2023-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
8,083 |
15,291 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
|
– • – |
2023-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
990 |
990 |
0 |
- |
|
| QTRX |
Quanterix Corp |
|
– • – |
2024-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
2,947 |
16,738 |
0 |
- |
|
| QTRX |
Quanterix Corp |
|
– • – |
2021-07-01 |
4 |
A |
$59.48 |
$6,186 |
D/D |
104 |
4,644 |
0 |
- |
|
| QTRX |
Quanterix Corp |
|
– • – |
2024-01-02 |
4 |
OE |
$12.86 |
$12,860 |
D/D |
1,000 |
17,738 |
0 |
- |
|
| QTRX |
Quanterix Corp |
|
– • – |
2024-04-01 |
4 |
OE |
$12.86 |
$12,860 |
D/D |
1,000 |
16,238 |
0 |
- |
|
| QTRX |
Quanterix Corp |
|
– • – |
2024-04-01 |
4 |
AS |
$23.50 |
$23,500 |
D/D |
(1,000) |
15,238 |
0 |
% |
|
| QTRX |
Quanterix Corp |
|
– • – |
2024-01-02 |
4 |
AS |
$26.91 |
$26,910 |
D/D |
(1,000) |
16,738 |
0 |
% |
|
| QTRX |
Quanterix Corp |
|
– • – |
2023-11-14 |
4 |
AS |
$21.89 |
$32,835 |
D/D |
(1,500) |
13,791 |
0 |
% |
|
| QTRX |
Quanterix Corp |
|
– • – |
2024-02-14 |
4 |
AS |
$24.35 |
$36,525 |
D/D |
(1,500) |
15,238 |
0 |
% |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2012-12-31 |
4 |
D |
$25.08 |
$49,157 |
D/D |
(1,960) |
28,644 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2014-02-24 |
4 |
D |
$31.99 |
$58,606 |
D/D |
(1,832) |
36,395 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2013-02-25 |
4 |
D |
$26.84 |
$58,967 |
D/D |
(2,197) |
26,665 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2015-02-23 |
4 |
D |
$34.39 |
$76,346 |
D/D |
(2,220) |
60,125 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
|
– • – |
2021-11-15 |
4 |
OE |
$84.86 |
$84,860 |
D/D |
1,000 |
1,000 |
0 |
- |
|
70 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
